Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples